Activities per year
Activities
- 7 results
Search results
-
Designing, executing and interpreting randomised clinical trials
Timothy Jackson (Invited speaker)
2 Sept 2022Activity: Talk or presentation › Oral presentation
-
Results of Part A of KALAHARI, a Phase 2 Trial of THR-149, a plasma kallikrein inhibitor, for the treatment of diabetic macular oedema
Timothy Jackson (Speaker)
2 Sept 2022Activity: Talk or presentation › Oral presentation
-
Designing, executing and interpreting randomized clinical trials
Timothy Jackson (Speaker)
2 Oct 2020Activity: Talk or presentation › Oral presentation
-
Vitrectomy, subretinal TPA and gas for submacular haemorrhage due to wet AMD
Timothy Jackson (Keynote speaker)
14 Feb 2020Activity: Talk or presentation › Oral presentation
-
A multicentre, randomised, double-masked, sham controlled study of intravitreal OPT-302 in combination with ranibizumab, for wet AMD
Timothy Jackson (Speaker)
15 Sept 2019Activity: Talk or presentation › Oral presentation
-
OPT-302 Phase 2b study in wet AMD: A multicentre, randomised, double-masked, sham controlled study of intravitreal OPT-302 in combination with ranibizumab, in participants with wet AMD
Timothy Jackson (Speaker)
5 Sept 2019Activity: Talk or presentation › Oral presentation
-
INTREPID year 3 safety results
Timothy Jackson (Speaker)
27 Jun 2018Activity: Talk or presentation › Oral presentation